| NONCODE ID | SNP ID | GWAS trait | Source PMID |
| NONHSAG002949.3 | rs4845420 | 2 hour glucose | 20081857 |
| NONHSAG002949.3 | rs4579760 | 2 hour glucose | 20081857 |
| NONHSAG002949.3 | rs924087 | Gene expression of S100A10 in CEU-CHB-JPT-YRI lymphoblastoid cell lines | 17873874 |
| NONHSAG002949.3 | rs924087 | 2 hour glucose | 20081857 |
| NONHSAG002949.3 | rs924088 | Total cholesterol | 20339536 |
| NONHSAG002949.3 | rs924088 | HDL cholesterol | 20339536 |
| NONHSAG002949.3 | rs17648141 | Methylation levels at chr1:150565458-150565508 [hg18 coord, probe cg13447818] in Caudal pons | 20485568 |
| NONHSAG002949.3 | rs17648141 | Methylation levels at chr1:150565458-150565508 [hg18 coord, probe cg13447818] in Frontal cortex | 20485568 |
| NONHSAG002949.3 | rs969359 | Crohn's disease, combined control dataset | 17554300 |
| NONHSAG002949.3 | rs969359 | Multiple complex diseases | 17554300 |
| NONHSAG002949.3 | rs12033248 | Methylation levels at chr1:150565458-150565508 [hg18 coord, probe cg13447818] in Temporal cortex | 20485568 |
| NONHSAG002949.3 | rs6667458 | Serum concentration of arachidonate (20:4n6) | 21886157 |
| NONHSAG002949.3 | rs6667458 | Serum concentration of deoxycholate | 21886157 |
| NONHSAG002949.3 | rs1496042 | Methylation levels at chr1:150565458-150565508 [hg18 coord, probe cg13447818] in Temporal cortex | 20485568 |
| NONHSAG002949.3 | rs1496042 | Gene expression of MTMR11 in liver | 18462017 |
| NONHSAG002949.3 | rs1496042 | Serum ratio of (arachidonate (20:4n6))/(caprylate (8:0)) | 21886157 |
| NONHSAG002949.3 | rs1496042 | Gene expression of S100A10 in blood | 21829388 |
| NONHSAG002949.3 | rs10749668 | Multiple sclerosis (females) | 19010793 |
| NONHSAG002949.3 | rs10749668 | Serum ratio of (gamma-glutamylisoleucine*)/(stearidonate (18:4n3)) | 21886157 |
| NONHSAG002949.3 | rs10788823 | Methylation levels at chr1:150565702-150565752 [hg18 coord, probe cg26390526] in Temporal cortex | 20485568 |
| NONHSAG002949.3 | rs10788823 | Birth weight | 23202124 |
| NONHSAG002949.3 | rs12130219 | Differential exon level expression of LOC339400 [probeset 2359264] in brain cortex | 19222302 |
| NONHSAG002949.3 | rs12130219 | Gene expression of LOC339400 [transcript ID 2359243] in brain cortex | 19222302 |
| NONHSAG002949.3 | rs12130219 | HDL cholesterol | 19060906 |
| NONHSAG002949.3 | rs4845733 | Serum ratio of (bilirubin (E,E)*)/(cysteine-glutathione disulfide) | 21886157 |
| NONHSAG002949.3 | rs11590365 | Serum ratio of (bilirubin (E,E)*)/(cysteine-glutathione disulfide) | 21886157 |
| NONHSAG002949.3 | rs1552991 | Gene expression of AK056431 in liver | 18462017 |
| NONHSAG002949.3 | rs1552991 | Methylation levels at chr1:150565458-150565508 [hg18 coord, probe cg13447818] in Temporal cortex | 20485568 |
| NONHSAG002949.3 | rs1552991 | Methylation levels at chr1:150565458-150565508 [hg18 coord, probe cg13447818] in Frontal cortex | 20485568 |
| NONHSAG002949.3 | rs1552991 | Gene expression of S100A10 in blood | 21829388 |
| NONHSAG002949.3 | rs10749669 | Serum ratio of (1,6-anhydroglucose)/(cysteine-glutathione disulfide) | 21886157 |
| NONHSAG002949.3 | rs877776 | Atopic dermatitis | 19349984 |
| NONHSAG002949.3 | rs4845741 | Serum ratio of (homocitrulline)/(pantothenate) | 21886157 |
| NONHSAG002949.3 | rs4845742 | Serum ratio of (homocitrulline)/(pantothenate) | 21886157 |
| NONHSAG002949.3 | rs4845743 | Methylation levels at chr1:150565458-150565508 [hg18 coord, probe cg13447818] in Temporal cortex | 20485568 |
| NONHSAG002949.3 | rs4845743 | Methylation levels at chr1:150565458-150565508 [hg18 coord, probe cg13447818] in Frontal cortex | 20485568 |
| NONHSAG002949.3 | rs4845743 | Serum ratio of (glycylvaline)/(homocitrulline) | 21886157 |
| NONHSAG002949.3 | rs4845423 | Serum ratio of (homocitrulline)/(pantothenate) | 21886157 |
| NONHSAG002949.3 | rs10888470 | Serum ratio of (bilirubin (E,E)*)/(cysteine-glutathione disulfide) | 21886157 |
| NONHSAG002949.3 | rs4845750 | Serum ratio of (1,6-anhydroglucose)/(cysteine-glutathione disulfide) | 21886157 |
| NONHSAG002949.3 | rs11581805 | Serum ratio of (pentadecanoate (15:0))/(scyllo-inositol) | 21886157 |
| NONHSAG002949.3 | rs12032307 | Methylation levels at chr1:150565458-150565508 [hg18 coord, probe cg13447818] in Temporal cortex | 20485568 |
| NONHSAG002949.3 | rs12032307 | Methylation levels at chr1:150565458-150565508 [hg18 coord, probe cg13447818] in Frontal cortex | 20485568 |
| NONHSAG002949.3 | rs12032307 | Methylation levels at chr1:150565702-150565752 [hg18 coord, probe cg26390526] in Cerebellum | 20485568 |
| NONHSAG002949.3 | rs17596572 | Methylation levels at chr1:150565458-150565508 [hg18 coord, probe cg13447818] in Temporal cortex | 20485568 |
| NONHSAG002949.3 | rs17596572 | Methylation levels at chr1:150565458-150565508 [hg18 coord, probe cg13447818] in Frontal cortex | 20485568 |
| NONHSAG002949.3 | rs17596572 | Methylation levels at chr1:150565702-150565752 [hg18 coord, probe cg26390526] in Cerebellum | 20485568 |
| NONHSAG002949.3 | rs12030180 | Serum ratio of (glycerol)/(myristoleate (14:1n5)) | 21886157 |
| NONHSAG002949.3 | rs2338430 | Urinary albumin-to-creatinine ratio | 21355061 |
| NONHSAG002949.3 | rs2132418 | Urinary albumin-to-creatinine ratio | 21355061 |
| NONHSAG002949.3 | rs11204947 | Urinary albumin-to-creatinine ratio | 21355061 |
| NONHSAG002949.3 | rs12030667 | Serum ratio of (1-eicosadienoylglycerophosphocholine*)/(palmitoylcarnitine) | 21886157 |
| NONHSAG002949.3 | rs11204949 | Serum ratio of (1-methylurate)/(trans-4-hydroxyproline) | 21886157 |
| NONHSAG002949.3 | rs10888473 | Serum ratio of (bilirubin (E,E)*)/(cysteine-glutathione disulfide) | 21886157 |
| NONHSAG002949.3 | rs6587655 | Serum creatinine | 20383146 |
| NONHSAG002949.3 | rs7537633 | Urinary albumin-to-creatinine ratio | 21355061 |
| NONHSAG002949.3 | rs4326625 | Urinary albumin-to-creatinine ratio | 21355061 |
| NONHSAG002949.3 | rs7527318 | Insulin resistance | 21901158 |
| NONHSAG002949.3 | rs7527318 | HOMA-IR | 21901158 |
| NONHSAG002949.3 | rs7527318 | Fasting insulin | 21901158 |
| NONHSAG002949.3 | rs7541297 | Insulin resistance | 21901158 |
| NONHSAG002949.3 | rs7541297 | HOMA-IR | 21901158 |
| NONHSAG002949.3 | rs7541297 | Fasting insulin | 21901158 |
| NONHSAG002949.3 | rs10888475 | Urinary albumin-to-creatinine ratio | 21355061 |
| NONHSAG002949.3 | rs10443208 | HDL cholesterol | 19060906 |
| NONHSAG002949.3 | rs4845431 | Serum ratio of (1-linoleoylglycerol (1-monolinolein))/(cholate) | 21886157 |
| NONHSAG002949.3 | rs12728907 | Multiple sclerosis (females) | 19010793 |
| NONHSAG002949.3 | rs11204971 | Atopic dermatitis | 21666691 |
| NONHSAG002949.3 | rs11204971 | Atopic dermatitis | 21666691 |
| NONHSAG002949.3 | rs11204971 | Serum ratio of (1-methylurate)/(trans-4-hydroxyproline) | 21886157 |
| NONHSAG002949.3 | rs2152862 | Serum ratio of (bilirubin (E,E)*)/(cysteine-glutathione disulfide) | 21886157 |
| NONHSAG002949.3 | rs56205414 | Multiple myeloma | 22120009 |
| NONHSAG002949.3 | rs2184951 | Urinary albumin-to-creatinine ratio | 21355061 |
| NONHSAG002949.3 | rs11204976 | Urinary albumin-to-creatinine ratio | 21355061 |
| NONHSAG002949.3 | rs12405278 | Serum ratio of (homocitrulline)/(octadecanedioate) | 21886157 |
| NONHSAG002949.3 | rs11204980 | Urinary albumin-to-creatinine ratio | 21355061 |
| NONHSAG002949.3 | rs6587666 | Urinary albumin-to-creatinine ratio | 21355061 |
| NONHSAG002949.3 | rs3126085 | Atopic dermatitis | 21666691 |
| NONHSAG002949.3 | rs3126085 | Atopic dermatitis | 21666691 |
| NONHSAG002949.3 | rs3126085 | Methylation levels at chr11:32409347-32409397 [hg18 coord, probe cg22533573] in Caudal pons | 20485568 |
| NONHSAG002949.3 | rs1933063 | Gene expression of ENOPH1 in peripheral blood monocytes | 20502693 |
| NONHSAG002949.3 | rs1933063 | Adiponectin levels | 22479202 |
| NONHSAG002949.3 | rs1858480 | Urinary albumin-to-creatinine ratio | 21355061 |
| NONHSAG002949.3 | rs3126091 | Urinary albumin-to-creatinine ratio | 21355061 |
| NONHSAG002949.3 | rs1858483 | Hair morphology | 19896111 |
| NONHSAG002949.3 | rs1858483 | Serum ratio of (gamma-glutamylglutamate)/(piperine) | 21886157 |
| NONHSAG002949.3 | rs2050631 | Serum concentration of 2-tetradecenoyl carnitine | 21886157 |
| NONHSAG002949.3 | rs3120665 | Cloninger?s temperament scales (Novelty seeking) | 20691247 |
| NONHSAG002949.3 | rs3120667 | 14-Item case/control for disordered eating behaviors | 23568457 |
| NONHSAG002949.3 | rs3120667 | Eating disorders | 23568457 |
| NONHSAG002949.3 | rs2065954 | Serum concentration of hexadecanedioate | 21886157 |
| NONHSAG002949.3 | rs11204982 | Serum concentration of arachidonate (20:4n6) | 21886157 |
| NONHSAG002949.3 | rs2282302 | Gene expression of PGLYRP4 [probe 220944_at] in prefrontal cortex | 20351726 |
| NONHSAG002949.3 | rs2282302 | HDL cholesterol | 19060906 |
| NONHSAG002949.3 | rs3818831 | Serum concentration of hexadecanedioate | 21886157 |
| NONHSAG002949.3 | rs11204985 | Serum ratio of (3-methylxanthine)/(pyroglutamylglycine) | 21886157 |
| NONHSAG002949.3 | rs6668764 | Serum ratio of (1-linoleoylglycerol (1-monolinolein))/(cholate) | 21886157 |
| NONHSAG002949.3 | rs10888484 | Gene expression of UNG2 in peripheral blood monocytes | 20502693 |
| NONHSAG002949.3 | rs1923504 | Monocyte count | 21738479 |
| NONHSAG002949.3 | rs10888485 | Monocyte count | 21738479 |
| NONHSAG002949.3 | rs16834014 | Serum ratio of (3-methylxanthine)/(pyroglutamylglycine) | 21886157 |
| NONHSAG002949.3 | rs11204998 | Serum ratio of (1,6-anhydroglucose)/(cysteine-glutathione disulfide) | 21886157 |
| NONHSAG002949.3 | rs12407319 | Serum ratio of (ornithine)/(tetradecanedioate) | 21886157 |
| NONHSAG002949.3 | rs4378206 | Serum ratio of (3-methylxanthine)/(pyroglutamylglycine) | 21886157 |
| NONHSAG002949.3 | rs7515448 | Serum ratio of (ornithine)/(tetradecanedioate) | 21886157 |
| NONHSAG002949.3 | rs3829868 | Serum ratio of (4-acetamidobutanoate)/(valerate) | 21886157 |
| NONHSAG002949.3 | rs4845763 | Serum concentration of urate | 21886157 |
| NONHSAG002949.3 | rs2146114 | Diabetic nephropathy in type 2 diabetes mellitus - end stage renal disease | 21150874 |
| NONHSAG002949.3 | rs10494275 | Serum ratio of (1-palmitoylglycerophosphoinositol*)/(3-hydroxy-2-ethylpropionate) | 21886157 |
| NONHSAG002949.3 | rs10494275 | Serum concentration of dehydroisoandrosterone sulfate (DHEA-S) | 21886157 |
| NONHSAG002949.3 | rs2146121 | Serum ratio of (arabinose)/(pyroglutamine*) | 21886157 |
| NONHSAG002949.3 | rs726863 | Serum concentration of bilirubin (Z,Z) | 21886157 |
| NONHSAG002949.3 | rs10888488 | Serum ratio of (arabinose)/(pyroglutamine*) | 21886157 |
| NONHSAG002949.3 | rs1923501 | Total cholesterol | 20339536 |
| NONHSAG002949.3 | rs11579266 | Serum ratio of (homocitrulline)/(octadecanedioate) | 21886157 |
| NONHSAG002949.3 | rs11579266 | Gene expression of LCE2C [probe ILMN_7772] in osteoblasts treated with BMP2 | 21283786 |
| NONHSAG002949.3 | rs11579266 | Total cholesterol | 20339536 |
| NONHSAG002949.3 | rs11577946 | Total cholesterol | 20339536 |
| NONHSAG002949.3 | rs4845769 | Autism | 20663923 |
| NONHSAG002949.3 | rs2146117 | 1,6-Anhydro-beta-D-glucose:Creatinine | 21572414 |
| NONHSAG002949.3 | rs2146117 | Total cholesterol | 20339536 |